| Literature DB >> 26068411 |
Mikael Anne Greenwood-Hickman1, Dori E Rosenberg2, Elizabeth A Phelan3, Annette L Fitzpatrick4.
Abstract
INTRODUCTION: Physical activity is known to prevent falls; however, use of widely available exercise programs for older adults, including EnhanceFitness and Silver Sneakers, has not been examined in relation to effects on falls among program participants. We aimed to determine whether participation in EnhanceFitness or Silver Sneakers is associated with a reduced risk of falls resulting in medical care.Entities:
Mesh:
Year: 2015 PMID: 26068411 PMCID: PMC4467255 DOI: 10.5888/pcd12.140574
Source DB: PubMed Journal: Prev Chronic Dis ISSN: 1545-1151 Impact factor: 2.830
Demographic Characteristics of EnhanceFitness Users and Nonusers, Washington State, United States, 2005–2011
| Trait | Nonusers, n = 55,127 | Consistent, n = 517 | Intermittent, n = 1,578 |
|
|---|---|---|---|---|
|
n (%) | ||||
|
| 74.1 (65–98) | 73.7 (65–95) | 75.0 (65–97) | <.001 |
|
| 30,640 (55.6) | 381 (73.7) | 1,169 (74.1) | <.001 |
|
| ||||
| White | 45,471 (90.6) | 436 (85.5) | 1,356 (88.6) | <.001 |
| Black | 1418 (2.8) | 21 (4.2) | 60 (3.9) | |
| Asian | 2,420 (4.8) | 40 (7.9) | 96 (6.3) | |
| Other | 880 (1.8) | 7 (1.4) | 19 (1.2) | |
|
| 28.3 (7.4–77.1) | 26.9 (16.3–45.7) | 27.3 (14.9–49.4) | <.001 |
| <18.5 | 531 (1.0) | 4 (0.8) | 12 (0.8) | <.001 |
| 18.5–24.9 | 8,851 (16.1) | 142 (27.1) | 367 (24.0) | |
| 25.0–29.9 | 11,142 (20.2) | 145 (28.1) | 428 (27.1) | |
| >30.0 | 34,603 (62.8) | 228 (44.1) | 771 (48.9) | |
|
| 4,359 (7.9) | 22 (4.3) | 59 (3.7) | <.001 |
|
| 0.92 (0-18) | 0.63 (0-10) | 0.60 (0-10) | <.001 |
| Diagnosis in study period | ||||
| Diabetes | 10,984 (19.9) | 87 (16.8) | 278 (17.6) | <.001 |
| Dementia | 1,965 (3.6) | 9 (1.7) | 63 (4.0) | .002 |
| Walking disorder | 624 (1.1) | 9 (1.7) | 37 (2.3) | .09 |
| Osteoarthritis | 22,801 (41.4) | 277 (53.6) | 990 (62.7) | <.001 |
| Osteoporosis | 873 (1.6) | 22 (4.3) | 63 (4.0) | <.001 |
| Musculoskeletal condition | 27,254 (49.4) | 330 (63.8) | 1,151 (72.9) | <.001 |
| Visual impairment | 31,894 (57.9) | 371 (71.8) | 1,271 (80.5) | <.001 |
| Coronary heart disease | 11,265 (20.4) | 99 (19.2) | 371 (23.5) | <.001 |
| Hypertension | 28,598 (51.9) | 306 (59.2) | 1,053 (66.7) | <.001 |
|
| 7,106 (12.9) | 43 (8.3) | 208 (13.2) | <.001 |
|
| 16,834 (30.5) | 146 (28.2) | 672 (42.6) | <.001 |
Abbreviation: BMI, body mass index; EF, EnhanceFitness.
Unless otherwise specified, traits are described at first enrollment. Analysis of variance (for continuous covariates) comparing trends in the covariate across levels of either EF or SS participation.
P values correspond to a Pearson’s χ2 analysis (for categorical covariates) or a 1-wayanalysis of variance (for continuous covariates) comparing trends in the covariate: race (6.1%), BMI (19.7%), and smoking (2.3%).
The following variables have missing values for some individuals: race (6.1%), BMI (19.7%), and smoking (2.3%). Percentages are approximate.
Charlson comorbidity score measures comorbidity based on the presence or absence of 19 conditions weighted for severity (continuous).
Includes difficulty walking (719.7), abnormal gait (781.2), and generalized weakness (728.87).
Includes arthropathy, rheumatoid arthritis, and joint derangement (712–719).
Includes glaucoma (365), cataract (366), macular degeneration (362.50–362.53, 362.55, 362.63), and retinopathy (362.01–362.03, 362.10, 362.11, 362.2, 363.31).
Demographic Characteristics of Silver Sneakers Users and Nonusers, Washington State, United States, 2005–2011
| Trait | Nonusers, n = 55,127 | Consistent, n = 3,953 | Intermittent, n = 9,623 |
|
|---|---|---|---|---|
|
n (%) | ||||
|
| 74.1 (65–98) | 70.0 (65–95) | 71.5 (65–96) | <.001 |
|
| 30,640 (55.6) | 2,377 (60.1) | 5,879 (61.1) | <.001 |
|
| ||||
| White | 45,471 (90.6) | 3,462 (91.6) | 8,571 (92.4) | <.001 |
| Black | 1,418 (2.8) | 65 (1.7) | 210 (2.3) | |
| Asian | 2,420 (4.8) | 202 (5.4) | 388 (4.2) | |
| Other | 880 (1.8) | 49 (1.3) | 109 (1.2) | |
|
| 28.3 (7.4–77.1) | 27.9 (16.2–51.7) | 28.6 (10.0–111.0) | <.001 |
| <18.5 | 531 (1.0) | 20 (0.5) | 31 (0.3) | <.001 |
| 18.5–24.9 | 8,851 (16.1) | 862 (21.8) | 1,565 (16.3) | |
| 25.0–29.9 | 11,142 (20.2) | 1,145 (29.0) | 2,253 (23.4) | |
| >30.0 | 34,603 (62.8) | 1,926 (48.7) | 5,774 (60.0) | |
|
| 4,359 (7.9) | 118 (3.0) | 485 (5.0) | <.001 |
|
| 0.92 (0–18) | 0.57 (0–10) | 0.61 (0–10) | <.001 |
|
| ||||
| Diabetes | 10,984 (19.9) | 572 (14.5) | 1,968 (20.5) | <.001 |
| Dementia | 1,965 (3.6) | 25 (0.6) | 214 (2.2) | <.001 |
| Walking disorder | 624 (1.1) | 34 (0.9) | 130 (1.4) | .09 |
| Osteoarthritis | 22,801 (41.4) | 1,854 (46.9) | 6,034 (62.7) | <.001 |
| Osteoporosis | 873 (1.6) | 108 (2.7) | 265 (2.8) | <.001 |
| Musculoskeletal condition | 27,254 (49.4) | 2,189 (55.4) | 6,893 (71.6) | <.001 |
| Visual impairment | 31,894 (57.9) | 2,446 (61.9) | 7,453 (77.5) | <.001 |
| Coronary heart disease | 11,265 (20.4) | 561 (14.2) | 2,226 (23.1) | <.001 |
| Hypertension | 28,598 (51.9) | 1850 (46.8) | 5,985 (62.2) | <.001 |
|
| 7,106 (12.9) | 344 (8.7) | 1,357 (14.1) | <.001 |
|
| 16,834 (30.5) | 861 (21.8) | 3,563 (37.0) | <.001 |
Abbreviation: BMI, body mass index; SS, Silver Sneakers.
Unless otherwise specified, traits are described at first enrollment. Values are presented as n (%) unless otherwise indicated.
P values correspond to a Pearson’s χ2 analysis (for categorical covariates) or a 1-way analysis of variance (for continuous covariates) comparing trends in the covariate across levels of program participation.
The following variables have missing values for some individuals: race (6.1%), BMI (19.7%), and smoking (2.3%). Percentages are approximate.
Charlson comorbidity score measures comorbidity based on the presence or absence of 19 conditions weighted for severity (continuous).
Includes difficulty walking (719.7), abnormal gait (781.2), and generalized weakness (728.87).
Includes arthropathy, rheumatoid arthritis, and joint derangement (712–719).
Includes glaucoma (365), cataract (366), macular degeneration (362.50–362.53, 362.55, 362.63), and retinopathy (362.01–362.03, 362.10, 362.11, 362.2, 363.31).
FigureKaplan–Meier survival curves of time to first medical fall for EnhanceFitness and Silver Sneakers users among enrollees of the Group Health Integrated Group Practice (Seattle, Washington), by consistent, intermittent, and nonusers.
Risk of a Medical Fall Among EF/SS Users Compared With Nonusers, Washington State, United States, 2005–2011
| Group | N | Crude Model, HR (95% CI) |
| Demographic Model, |
| Full Model, |
| |
|---|---|---|---|---|---|---|---|---|
| EF | Nonusers | 55,127 | 1 [Reference] | — | 1 [Reference] | — | 1 [Reference] | — |
| Intermittent | 1,578 | 0.90 (0.84–0.98) | .009 | 0.84 (0.77–0.91) | <.001 | 0.87 (0.80–0.94) | .001 | |
| Consistent | 517 | 0.73 (0.62–0.86) | <.001 | 0.71 (0.60–0.84) | <.001 | 0.74 (0.63–0.88) | <.001 | |
|
| ||||||||
| SS | Nonusers | 55,127 | 1 [Reference] | — | 1 [Reference] | — | 1 [Reference] | — |
| Intermittent | 9,623 | 0.85 (0.82–0.88) | <.001 | 0.92 (0.88–0.95) | <.001 | 0.93 (0.90–0.97) | <.001 | |
| Consistent | 3,953 | 0.83 (0.78–0.89) | <.001 | 0.93 (0.87–0.99) | .03 | 0.95 (0.89–1.02) | .18 | |
Abbreviations: CI, confidence interval; EF, EnhanceFitness; HR, hazard ratio; SS, Silver Sneakers..
Model adjusted for age, sex, and race.
Model adjusted for age, sex, race, and all covariates outlined in Tables 1 and 2.